DRTS Alpha Tau Medical: Multiplikator nilai perusahaan marang pendapatan

Alpha Tau Medical (DRTS) - logo korporat

Alpha Tau Medical Ltd. (DRTS) is integrating ESG principles into the development of alpha-therapy systems by controlling isotope disposal. The historical EV/Sales trend illustrates the business valuation dynamics, where the 0.00 mark reflects the current state. However, narrow specialization and technology implementation challenges create risks for profitability. The Israeli developer is currently focusing on the organic growth of laboratories in the US, conducting global trials independently.

DRTS: Multiplikator EV/Sales Alpha Tau Medical Ltd. 23.11.2025 - 20.11.2026

DRTS (Alpha Tau): rincian analitis lan laporan miturut indikator

- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:DRTS, Alpha Tau Medical Ltd.
Barang utama Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. (DRTS) is integrating bioethics principles and ESG standards into the production of alpha-therapy systems. The EV/Revenue multiple assesses the business value inclusive of net debt, eliminating the impact of the financing structure. This indicator measures the market value of one dollar of sales, reflecting investor expectations regarding growth rates. This chart reveals an overvaluation of assets amid technological breakthroughs. A decline in this metric signals that the company is undervalued relative to its operational efficiency.